Wall Street is on the brink of achieving new highs, despite some setbacks. The S&P 500 is inching closer to its record high set in October, while the Dow Jones Industrial Average has surged by 664 points, or 1. 4%. However, the Nasdaq composite has taken a slight dip of 0. 2%, largely due to worries
A new drug called retatrutide has shown some amazing results in a recent trial. People who took it lost a lot of weight and felt less pain in their knees. This drug is made by a company called Eli Lilly, which already has other popular drugs for weight loss and diabetes. The trial lasted about a ye
Huntsville, Alabama, is about to get a major boost. Eli Lilly, a big name in the pharmaceutical world, is putting $6 billion into a new facility there. This isn't just any old factory; it's a high-tech hub for making advanced medicines. The focus will be on small molecule synthetic and peptide medic
A renowned science journalist has passed away at the age of 92. John Noble Wilford spent his career writing about incredible scientific achievements. He was there when humans first set foot on the moon. His words brought the excitement of that moment to life for readers everywhere. Wilford's report
In 2025, a bunch of amazing books hit the shelves. They covered all sorts of topics, from romance to sci-fi, and everything in between. Here's a closer look at some of the standout titles that had everyone talking. One book that stole the show was "Atmosphere" by Taylor Jenkins Reid. It's a grippin
A recent trade agreement between the U. S. and the U. K. has sparked discussions about job creation and pharmaceutical trade. The deal, which eliminates tariffs on U. K. medicines exported to the U. S. for three years, comes with a catch. In exchange, U. K. drug companies must invest more in the U.
Eli Lilly has decided to lower the prices of its weight loss drug, Zepbound, for people who pay out of pocket. This change is part of a bigger effort to make the medication more accessible to those who need it. The company announced that starting this week, the initial dose of Zepbound vials will co
Eli Lilly has made a big move to make its weight-loss drug, Zepbound, more affordable. They've lowered the price of single-dose vials, hoping more people can get their hands on it. Now, the starting dose is $299 a month, down from $349. Higher doses are also cheaper now, with the 5 mg dose at $399 a
Lilly Williamson, a senior at Lake City High School, has a clear vision for her future. She wants to be a nurse, inspired by her own experiences with medical care. At just seven years old, she faced a serious bacterial infection called mastoiditis, which led to multiple surgeries. This tough time in
Thanksgiving Day is here, but the stock market doesn't stop for holidays. Let's look at some big news from today. Toyota is seeing more cars sold in the U. S. October 2025 was a good month for them. This is great news for the company. Microsoft is putting money into solar projects in Mexico, Braz
